Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases

Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases

Show other versions (1)

Bibliographic Details
Main Authors:	Ponte, C, Sznajd, J, O'Neill, L, Luqmani, R
Format:	Journal article
Published:	2014

Similar Items

Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases.
by: Ponte, C, et al.
Published: (2014)

Clinical features and structured clinical evaluation of vasculitis
by: Ponte, C, et al.
Published: (2018)

276 The short-term damage burden in vasculitis and vasculitis mimics as measured by the vasculitis damage index
by: Floris, A, et al.
Published: (2016)

Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis
by: Hellmich, B, et al.
Published: (2006)

Optimisation of cyclophosphamide therapy in systemic vasculitis.
by: Richmond, R, et al.
Published: (1998)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
by: Luqmani, R, et al.
Published: (2007)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
by: Luqmani, R, et al.
Published: (2017)

Maintenance of clinical remission in ANCA-associated vasculitis.
by: Luqmani, R
Published: (2013)

Opinion: Maintenance of clinical remission in ANCA-associated vasculitis
by: Luqmani, R
Published: (2013)

Vasculitis integrated total assessment log (VITAL): A system for clinical evaluation of vasculitis.
by: Luqmani, R, et al.
Published: (1996)

Long-term survival of ANCA-associated vasculitis
by: Flossmann, O, et al.
Published: (2009)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
by: Hellmich, B, et al.
Published: (2007)

Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS)
by: Nakagomi, D, et al.
Published: (2017)

Disease assessment in systemic vasculitis
by: Luqmani, R
Published: (2004)

Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials
by: Luqmani, R, et al.
Published: (2001)

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
by: Mukhtyar, C, et al.
Published: (2007)

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.
by: Bacon, P, et al.
Published: (1995)

Using the Birmingham Vasculitis Activity Score as a Screening Tool in Patients with Suspected Vasculitis
by: Floris, A, et al.
Published: (2016)

Assessment of systemic vasculitis.
by: Miller, A, et al.
Published: (2008)

Validation of the Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials.
by: Luqmani, R, et al.
Published: (2000)

DIAGNOSIS AND ASSESSMENT OF LARGE VESSEL VASCULITIS
by: Luqmani, R
Published: (2011)

SP0189 Hot session: interactive clinical aspects and cases on vasculitis treatment
by: Luqmani, R
Published: (2017)

Long-term patient survival in ANCA-associated vasculitis
by: Flossmann, O, et al.
Published: (2011)

Long-term patient survival in ANCA-associated vasculitis.
by: Flossmann, O, et al.
Published: (2011)

OP0055 Using the Birmingham Vasculitis Activity Score as a screening tool in patients with suspected vasculitis
by: Floris, A, et al.
Published: (2016)

Long-term patient survival in ANCA-associated vasculitis.
by: Flossmann, O, et al.
Published: (2011)

Damage assessment in ANCA-associated vasculitis.
by: Bhamra, K, et al.
Published: (2012)

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
by: Merkel, P, et al.
Published: (2011)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
by: Robson, J, et al.
Published: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
by: Robson, J, et al.
Published: (2015)

Vasculitis: an update.
by: Luqmani, R
Published: (2014)

Vasculitis: an update.
by: Luqmani, R
Published: (2014)

Diagnosis and assessment of systemic vasculitis.
by: McLaren, J, et al.
Published: (2002)

284 Differences in early damage patterns in various forms of primary systemic vasculitis
by: Wawrzycka-Adamczyk, K, et al.
Published: (2016)

Outpatient assessment of systemic vasculitis.
by: Nataraja, A, et al.
Published: (2007)

Discontinuation of therapies in vasculitis.
by: Luqmani, R
Published: (2013)

Discontinuation of therapies in vasculitis.
by: Luqmani, R
Published: (2013)

Discontinuation of therapies in vasculitis.
by: Luqmani, R
Published: (2013)

CLASSIFICATION AND DIAGNOSIS OF VASCULITIS
by: Luqmani, R
Published: (2012)

Pharmacotherapy of vasculitis.
by: Chan, M, et al.
Published: (2009)